\-\ Texto\\:\\ \ \(0\)\
\-\ aao\\,\\ nad\ \(0\)\
\-\ perrl\\,\\ eomi\ \(0\)\
\-\ face\\ symmetric\\,\\ tongue\\ midline\ \(0\)\
\-\ mild\\ right\\ uvular\\ deviation\ \(0\)\
\-\ speech\\:\\ fluent\\,\\ naming\\,\\ comprehension\\ intact\ \(0\)\
\-\ neg\\ drift\ \(0\)\
\-\ right\\:\\ \\ \\ 5\\ 5\\ 5\\ 5\\ 5\\ \\|\\ \\ 5\\ \\ 5\\ \\ 5\\ \\ 5\\ \\ 5\ \(0\)\
\-\ left\\:\\ \\ \\ \\ \\ 5\\ 5\\ 5\\ 5\\ 5\\ \\|\\ \\ 5\\ \\ 5\\ \\ 5\\ \\ 5\\ \\ 5\ \(0\)\
\-\ mild\\ dysmetria\\ rue\\ ftf\ \(0\)\
\-\ scheduled\\ for\\ right\\ frontal\\ craniotomy\\,\\ stealth\\-guided\\ resection\\ of\\ frontal\\ lesions\ \(0\)\
\-\ frozen\\ of\\ medial\\ lesion\\ sent\\ \\(specimen\\ appeared\\ to\\ be\\ glial\\ in\\ nature\\)\ \(0\)\
\-\ complete\\ resection\\ of\\ lesions\\ ensued\ \(0\)\
\-\ two\\ enhancing\\ right\\ frontal\\ lesions\\ w\\/o\\ significant\\ surrounding\\ vasogenic\\ edema\ \(0\)\
\-\ astrocytoma\\ who\\ gr\\ 4\\ \\(glioblastoma\\)\\,\\ multifocal\ \(0\)\
\-\ prostate\\ metastasis\ \(0\)\
\-\ cns\\ lymphoma\ \(0\)\
\-\ metastasis\\ from\\ unkown\\ 2nd\\ primary\ \(0\)\
\-\ multi\\-focal\\ glioma\ \(0\)\
\-\ 69\\ y\\.o\\.\\ rhd\\ man\\ with\\ new\\ onset\\ seizure\\ \\(left\\)\\.\ \(0\)\
\-\ presented\\ to\\ local\\ er\\ after\\ seizure\\,\\ became\\ unresponsive\\,\\ and\\ was\\ intubated\\.\\ \\ screening\\ ct\\ was\\ abnormal\\.\ \(0\)\
\-\ later\\,\\ he\\ was\\ extubated\\ and\\ discharged\\ on\\ aed\\ \\(anti\\-epileptic\\ drugs\\)\\.\\ \\ he\\ was\\ readmitted\\ for\\ fevers\\ and\\ uti\\ 4\\ days\\ later\\.\ \(0\)\
\-\ pmh\\/psh\\:\\ \ \(0\)\
\-\ prostate\\ ca\\ 3\\+3\\,\\ stable\\ on\\ recent\\ trus\\ fusion\ \(0\)\
\-\ osa\ \(1167\)\
\-\ htn\ \(15\)\
\-\ meds\\:\\ \\ keppra\\,\\ benezapril\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ prostate\\:\\ 0\\.17174253782488869\ \(0\)\
\-\ frontal\\:\\ 0\\.17118348330333236\ \(0\)\
\-\ lesions\\:\\ 0\\.15274787085855385\ \(0\)\
\-\ seizure\\:\\ 0\\.14754578473739244\ \(0\)\
\-\ uvular\\:\\ 0\\.14177971669249725\ \(0\)\
\-\ ftf\\:\\ 0\\.14177971669249725\ \(0\)\
\-\ ensued\\:\\ 0\\.14177971669249725\ \(0\)\
\-\ aed\\:\\ 0\\.14177971669249725\ \(0\)\
\-\ trus\\:\\ 0\\.14177971669249725\ \(0\)\
\-\ benezapril\\:\\ 0\\.14177971669249725\ \(0\)\
\-\ osa\\:\\ 0\\.1354780883708039\ \(0\)\
\-\ naming\\:\\ 0\\.13100701192266237\ \(0\)\
\-\ unkown\\:\\ 0\\.13100701192266237\ \(0\)\
\-\ metastasis\\:\\ 0\\.12995611106070296\ \(0\)\
\-\ aao\\:\\ 0\\.12753897559932545\ \(0\)\
\-\ rhd\\:\\ 0\\.12753897559932545\ \(0\)\
\-\ later\\:\\ 0\\.1268927844962278\ \(0\)\
\-\ comprehension\\:\\ 0\\.12470538360096906\ \(0\)\
\-\ was\\:\\ 0\\.12358951488033203\ \(0\)\
\-\ keppra\\:\\ 0\\.12230961570286278\ \(0\)\
\-\ rue\\:\\ 0\\.12023430715282751\ \(0\)\
\-\ readmitted\\:\\ 0\\.12023430715282751\ \(0\)\
\-\ fluent\\:\\ 0\\.11840375527927571\ \(0\)\
\-\ dysmetria\\:\\ 0\\.11840375527927571\ \(0\)\
\-\ right\\:\\ 0\\.1175720912027301\ \(0\)\
\-\ extubated\\:\\ 0\\.11676627082949058\ \(0\)\
\-\ glial\\:\\ 0\\.11528498596332055\ \(0\)\
\-\ drift\\:\\ 0\\.11393267883113418\ \(0\)\
\-\ frozen\\:\\ 0\\.11393267883113418\ \(0\)\
\-\ resection\\:\\ 0\\.11365887551590884\ \(0\)\
\-\ perrl\\:\\ 0\\.10851939101587181\ \(0\)\
\-\ gr\\:\\ 0\\.10851939101587181\ \(0\)\
\-\ he\\:\\ 0\\.10499727602061082\ \(0\)\
\-\ unresponsive\\:\\ 0\\.10132942218774753\ \(0\)\
\-\ mild\\:\\ 0\\.10051275744104855\ \(0\)\
\-\ uti\\:\\ 0\\.09868889761315777\ \(0\)\
\-\ meds\\:\\ 0\\.09685834573960599\ \(0\)\
\-\ eomi\\:\\ 0\\.09643251834218883\ \(0\)\
\-\ tongue\\:\\ 0\\.09561434376869897\ \(0\)\
\-\ neg\\:\\ 0\\.09561434376869897\ \(0\)\
\-\ craniotomy\\:\\ 0\\.09483709542754454\ \(0\)\
\-\ specimen\\:\\ 0\\.0944625778414997\ \(0\)\
\-\ intubated\\:\\ 0\\.09373957642365081\ \(0\)\
\-\ 69\\:\\ 0\\.09304871923183833\ \(0\)\
\-\ speech\\:\\ 0\\.0914450579243436\ \(0\)\
\-\ deviation\\:\\ 0\\.08918044462523587\ \(0\)\
\-\ drugs\\:\\ 0\\.08866233905733067\ \(0\)\
\-\ glioblastoma\\:\\ 0\\.08840962246889426\ \(0\)\
\-\ htn\\:\\ 0\\.08840962246889426\ \(0\)\
\-\ nad\\:\\ 0\\.08816094951980637\ \(0\)\
\-\ appeared\\:\\ 0\\.0876752309972205\ \(0\)\
\-\ vasogenic\\:\\ 0\\.08720423350604393\ \(0\)\
\-\ became\\:\\ 0\\.08697398147620207\ \(0\)\
\-\ multifocal\\:\\ 0\\.08608564096977112\ \(0\)\
\-\ sent\\:\\ 0\\.08296687165381594\ \(0\)\
\-\ cns\\:\\ 0\\.08279125704238129\ \(0\)\
\-\ scheduled\\:\\ 0\\.08227601446200346\ \(0\)\
\-\ 2nd\\:\\ 0\\.08113631978026414\ \(0\)\
\-\ face\\:\\ 0\\.07992858790224418\ \(0\)\
\-\ nature\\:\\ 0\\.07827658525640246\ \(0\)\
\-\ fevers\\:\\ 0\\.07827658525640246\ \(0\)\
\-\ local\\:\\ 0\\.07631597632474084\ \(0\)\
\-\ discharged\\:\\ 0\\.07608741738578233\ \(0\)\
\-\ symmetric\\:\\ 0\\.07597438614031012\ \(0\)\
\-\ ca\\:\\ 0\\.07564014255386466\ \(0\)\
\-\ glioma\\:\\ 0\\.07531293619993625\ \(0\)\
\-\ fusion\\:\\ 0\\.07447263816684102\ \(0\)\
\-\ screening\\:\\ 0\\.07201855227254642\ \(0\)\
\-\ stable\\:\\ 0\\.07012990041451572\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.06692700787424069\ \(0\)\
\-\ midline\\:\\ 0\\.06667733619574023\ \(0\)\
\-\ er\\:\\ 0\\.06631019169572411\ \(0\)\
\-\ intact\\:\\ 0\\.0641669987622292\ \(0\)\
\-\ complete\\:\\ 0\\.0621444635319951\ \(0\)\
\-\ new\\:\\ 0\\.0613334067638728\ \(0\)\
\-\ left\\:\\ 0\\.060484765220909495\ \(0\)\
\-\ recent\\:\\ 0\\.06002873434084452\ \(0\)\
\-\ surrounding\\:\\ 0\\.059126943614839\ \(0\)\
\-\ medial\\:\\ 0\\.05770811721617946\ \(0\)\
\-\ onset\\:\\ 0\\.05692832501255131\ \(0\)\
\-\ days\\:\\ 0\\.05612287391725747\ \(0\)\
\-\ enhancing\\:\\ 0\\.05553748692588924\ \(0\)\
\-\ and\\:\\ 0\\.05495882638152083\ \(0\)\
\-\ primary\\:\\ 0\\.05451367287427426\ \(0\)\
\-\ for\\:\\ 0\\.0537417063336961\ \(0\)\
\-\ on\\:\\ 0\\.05355106816791606\ \(0\)\
\-\ abnormal\\:\\ 0\\.053263139393395775\ \(0\)\
\-\ edema\\:\\ 0\\.052876188424489115\ \(0\)\
\-\ lymphoma\\:\\ 0\\.052799941038124146\ \(0\)\
\-\ two\\:\\ 0\\.05264855937620299\ \(0\)\
\-\ of\\:\\ 0\\.05204856661885137\ \(0\)\
\-\ presented\\:\\ 0\\.05169896511608864\ \(0\)\
\-\ significant\\:\\ 0\\.05118783084336052\ \(0\)\
\-\ who\\:\\ 0\\.0501491199942711\ \(0\)\
\-\ man\\:\\ 0\\.04693541244634459\ \(0\)\
\-\ to\\:\\ 0\\.04432748669688519\ \(0\)\
\-\ after\\:\\ 0\\.0430083188324422\ \(0\)\
\-\ lesion\\:\\ 0\\.04250350038956659\ \(0\)\
\-\ be\\:\\ 0\\.03596406104987952\ \(0\)\
\-\ from\\:\\ 0\\.03521027350579172\ \(0\)\
\-\ ct\\:\\ 0\\.033752045931793165\ \(0\)\
\-\ in\\:\\ 0\\.02205465344958425\ \(0\)\
\-\ with\\:\\ 0\\.01735988854166788\ \(0\)\
